Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
After carefully considering benefits and risks to patients we think it’s critical patients have access to the drugs while impurity-free losartan is manufactured. We believe this will NOT meaningful increase risks over the time it will take to get impurity-free losartan to market
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.